Atlas maps plasma proteins to transform disease diagnosis and treatment

Researchers have developed the most comprehensive atlas linking plasma proteins to diseases and traits in over 53,000 individuals, offering groundbreaking insights for precision medicine. This resource uncovers 168,100 protein-disease associations and identifies new therapeutic targets.

Donanemab: FDA AdCom will put spotlight on tau enrolment and ARIA concerns

Share this article Eli Lilly said the FDA wants the AdCom to better understand efficacy implications of its unique trial design. Image credit: Shutterstock /

March 21, 2024

Eiger files for bankruptcy and will wind down operations after years of setbacks

Eiger BioPharmaceuticals said Monday morning that it filed for Chapter 11 protection in the United States Bankruptcy Court for the Northern District of Texas. The

April 2, 2024

Study reveals novel mechanism for longevity of oocytes

Oocytes are immature egg cells that develop in almost all female mammals before birth. The propagation of future generations depends on this finite reserve of

February 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.